Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations

SIMPLE SUMMARY: Over the past decade, randomized controlled trials as an established instrument of evidence-based medicine have contributed fundamentally to the development and approval of new substances. However, it has been frequently shown that less than 5% of adult cancer patients enroll in clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Boquoi, Amelie, Rings, Veronika, Mohring, Annemarie, Savickaite, Ingrida, Zukovs, Romans, Strapatsas, Judith, Nachtkamp, Kathrin, Kobbe, Guido, Germing, Ulrich, Fenk, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106039/
https://www.ncbi.nlm.nih.gov/pubmed/35565276
http://dx.doi.org/10.3390/cancers14092147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106039/
https://www.ncbi.nlm.nih.gov/pubmed/35565276
http://dx.doi.org/10.3390/cancers14092147

Ejemplares similares